Skip to main content

UBS Group AG

Position in PHIO — Phio Pharmaceuticals Corp.

CIK 1610520 ZURICH, V8

Position in PHIO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$5,521
-$27,402 QoQ
Shares Held
5,387
-80.0% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 24 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PHIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. PHIO ranks #470 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PHIO

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,521 5,387
2026-03-31 $32,923 26,987
2025-12-31 $9,023 8,594
2025-09-30 $32 13
2025-03-31 $133 103
2024-12-31 $4,314 2,397
2024-09-30 $5,813 1,685
2024-06-30 $1,693 2,447
2024-03-31 $923 1,358
2023-03-31 $1,163 207
2022-12-31 $8,566 23,029
2022-03-31 $2,381 2,685
2021-12-31 $7,000 7,000
2021-09-30 $12,669 6,241
2021-06-30 $3,112 1,377
2020-12-31 $15,125 5,623
2020-09-30 $1,211 566
2020-06-30 $24,438 11,159
2020-03-31 $996 563